A study to assess the effects of two drugs,topical methotrexate gel and topical mometasone furoate ointment in patients with psoriasis.
Phase 4
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2023/10/058439
- Lead Sponsor
- Dr Shivani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Not using topical psoriasis treatment for at least 2weeks before the start of study.
2.Patients having mild to moderate chronic plaque psoriasis.
Exclusion Criteria
1.Use of Phototherapy,PUVA or systemic therapy for psoriasis within 8 weeks before the start of study.
2.Pregnant and lactating women and women of child bearing potential who are not practicing an acceptable method of birth control.
4.Patients of unstable,erythrodermic,pustular and guttate psoriasis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method